Friday 6 November 2026 Export BNTX’s income statement to Excel — free account

BioNTech SE Sponsored ADR

BioNTech SE Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 9.07% from fiscal 2024.

Revenue: −16.4%
EPS: +708.4%
Free cash flow: −123.8%
Total debt: +44.4%

Quarter to September 2026, against a year earlier

87.12 1.26 +1.47%

Follow BNTX

Alert me

Market cap: $21.6B
P/E: 0.0×
Fwd P/E: −13.5×
Dividend yield: —
F-score: 4/9
Altman Z: n/a
Beneish M: −2.74
Dividend safety: n/a

Overview

BioNTech SE Sponsored ADR (BNTX) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, BioNTech SE Sponsored ADR (BNTX) trades at a P/B ratio of 1.1×. Over the past ten years it has ranged from 0.9× (June 2024) to 42.7× (March 2020); the current reading is higher than 11% of that period. That is below the Biotechnology industry median of 2.0× and below the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BNTX/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="BioNTech SE Sponsored ADR P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BNTX/metrics/pb-ratio">BioNTech SE Sponsored ADR (BNTX) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	1.1×	(18.89%)
FY2024	1.3×	5.72%
FY2023	1.2×	(27.93%)
FY2022	1.7×	(61.71%)
FY2021	4.5×	(63.50%)
FY2020	12.2×	(22.15%)
FY2019	15.7×	137.92%
FY2018	6.6×	0.00%
FY2017	6.6×	—

Period	P/B ratio	Change
Sep 2026	1.2×	5.31%
Jun 2026	1.1×	11.00%
Mar 2026	1.0×	(2.77%)
Dec 2025	1.1×	(3.13%)
24 more quarters	Free account

Against its own ten years

Low 0.9× High 42.7×

Ten-year median 1.4×

Current reading's percentile 11

Company	P/B ratio
BBIO BridgeBio Pharma, Inc. compare	n/m
BNTX BioNTech SE Sponsored ADR	1.1×
INCY Incyte Corporation compare	4.3×
ROIV Roivant Sciences Ltd. compare	5.4×
GMAB Genmab A/S Sponsored ADR compare	5.5×
ALNY Alnylam Pharmaceuticals, Inc. compare	5.8×
EXEL Exelixis, Inc. compare	9.3×
ASND Ascendis Pharma A/S compare	9.8×
INSM Insmed, Inc. compare	32.6×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

BioNTech SE Sponsored ADR (BNTX) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on BNTX

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on BNTX

Stockrow Weekly